Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
EV/EBITDA
37.57 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Valeant Pharmaceuticals International Inc's enterprise value is $57,638 Mil. Valeant Pharmaceuticals International Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2013 was $1,546 Mil. Therefore, Valeant Pharmaceuticals International Inc's EV/EBITDA ratio for today is 37.57.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Valeant Pharmaceuticals International Inc's stock price is $122.05. Valeant Pharmaceuticals International Inc's earnings per share for the trailing twelve months (TTM) ended in Dec. 2013 was $-2.61. Therefore, Valeant Pharmaceuticals International Inc's P/E Ratio for today is 0.00.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Valeant Pharmaceuticals International Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=57638.174/1545.67
=37.29

Valeant Pharmaceuticals International Inc's current Enterprise Value is $57,638 Mil.
Valeant Pharmaceuticals International Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2013 was 441.966 (Mar. 2013 ) + 454.302 (Jun. 2013 ) + 54.062 (Sep. 2013 ) + 595.34 (Dec. 2013 ) = $1,546 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Valeant Pharmaceuticals International Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=122.05/-2.61
=

Valeant Pharmaceuticals International Inc's share price for today is $122.05.
Valeant Pharmaceuticals International Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2013 was -0.09 (Mar. 2013 ) + 0.03 (Jun. 2013 ) + -2.92 (Sep. 2013 ) + 0.37 (Dec. 2013 ) = $-2.61.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda 10.078.938.885.425.377.09115.5322.4126.3236.21

Valeant Pharmaceuticals International Inc Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebitda 21.7022.4122.2918.9821.9826.3227.2527.0944.8236.21
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide